AGMB · Agomab Therapeutics NV
Market Cap
$648.60M
Shares
49.25M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.
Key facts
CIK
2020932
CUSIP
00860C102
13F (30d)
28 filings
28 filers
Visit website
Investor relations